PPAR alpha/gamma agonists (CrystalGenomics)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NamePPAR alpha/gamma agonists (CrystalGenomics)

Drug Alias NameCG-301360CG-301269

ClassificationSmall molecules

Mechanisms of ActionPeroxisome proliferator-activated receptor α agonistsInsulin sensitizersPeroxisome proliferator-activated receptor γ agonists

TargetsPeroxisome proliferator-activated receptor αPeroxisome proliferator-activated receptor γ

Therapy Area/IndicationsHyperlipidemiasInsulin Resistance

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCrystalgenomics Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsHyperlipidemiasInsulin Resistance

ATC CodeN/A